{"altmetric_id":15170126,"counts":{"readers":{"mendeley":6,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["Thomas_Wilckens"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa4d83cf058f610001384","authors":["Willem Hulsink"],"doi":"10.1080\/13691066.2017.1261454","endpage":"118","first_seen_on":"2016-12-31T15:16:15+00:00","issns":["1369-1066","1464-5343"],"issue":"1-2","journal":"Venture Capital","last_mentioned_on":1483197360,"links":["http:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/13691066.2017.1261454?utm_content=buffer6504a&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer"],"pubdate":"2016-12-27T00:00:00+00:00","publisher_subjects":[{"name":"Business And Management","scheme":"era"}],"scopus_subjects":["Social Sciences","Economics, Econometrics and Finance"],"startpage":"95","title":"Dedicated funding for leasing and sharing research and test facilities and its impact on innovation, follow-on financing and growth of biotech start-ups: the Mibiton case","type":"article","volume":"19","mendeley_url":"http:\/\/www.mendeley.com\/research\/dedicated-funding-leasing-sharing-research-test-facilities-impact-innovation-followon-financing-grow"},"altmetric_score":{"score":0.25,"score_history":{"1y":0.25,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":{"all":{"total_number_of_other_articles":7965219,"mean":6.7280072798953,"rank":6893061,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":7965219,"percentile":1},"similar_age_3m":{"total_number_of_other_articles":253435,"mean":12.491116440572,"rank":208695,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":253435,"percentile":1},"this_journal":{"total_number_of_other_articles":49,"mean":2.9052083333333,"rank":44,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":49,"percentile":1},"similar_age_this_journal_3m":{"total_number_of_other_articles":2,"mean":1,"rank":2,"this_scored_higher_than_pct":1,"this_scored_higher_than":0,"rank_type":"exact","sample_size":2,"percentile":1}}},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Unspecified":1,"Student  > Master":1,"Professor":1,"Student  > Ph. D. Student":2,"Student  > Doctoral Student":1},"by_discipline":{"Economics, Econometrics and Finance":2,"Business, Management and Accounting":3,"Unspecified":1}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/Thomas_Wilckens\/statuses\/815214934434975744","license":"gnip","citation_ids":[15170126],"posted_on":"2016-12-31T15:16:00+00:00","author":{"name":"Dr. Thomas Wilckens","url":"http:\/\/www.InnVentis.com","image":"https:\/\/pbs.twimg.com\/profile_images\/460310079577669633\/1H8zg1xs_normal.jpeg","description":"MD, #PRECISIONMEDICINE leader: Changing the way we diagnose, treat  and eventually prevent disease.  #BigDATA and #MachineLearning applied to #omics","id_on_source":"Thomas_Wilckens","tweeter_id":"2149170848","geo":{"lt":null,"ln":null},"followers":1806},"tweet_id":"815214934434975744"}]}}